ArticleJournal of carcinogenesis2011

Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.

Tameka A Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.